Nature

Positron Emission Tomography and Positronium Research

Positron Emission Tomography (PET) has long served as a critical medical imaging modality, enabling the visualisation of biochemical processes in vivo using positron-emitting radiotracers. Recent ...
EurekAlert!

Positron emission tomography in psychiatry: Dr. Romina Mizrahi maps the molecular future

MONTRÉAL, Québec, Canada, 8 April 2025 – In a powerful and deeply reflective Genomic Press Interview, published in Brain Medicine, Dr. Romina Mizrahi, Professor of Psychiatry at McGill University and ...
Nature

Positron Emission Tomography and Computed Tomography Imaging Techniques

Positron Emission Tomography (PET) and Computed Tomography (CT) are complementary imaging modalities that have revolutionised diagnostic and research strategies in modern medicine. PET exploits the ...
ascopubs.org

Mid-Treatment Positron Emission Tomography–Adaptive Radiotherapy in Stage III Non–Small Cell Lung Cancer: Another Attempt Toward Personalized Care

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
National Academies of Sciences%2c Engineering%2c and Medicine

Mathematics and Physics of Emerging Biomedical Imaging

Suggested Citation: "6 POSITRON EMISSION TOMOGRAPHY." National Research Council. 1996. Mathematics and Physics of Emerging Biomedical Imaging. Washington, DC: The National Academies Press. doi: ...
Finger Lakes Times

NYS and NYRA support Cornell study to protect thoroughbreds

Cornell University’s College of Veterinary Medicine has commenced a comprehensive three-year study to improve detection of thoroughbred racehorse injuries. Data will be provided by horses seen at Corn ...

Registrational Phase III AMPLIFY trial: Target number of participants achieved

Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...
ascopubs.org

Erratum: Mid-Treatment Positron Emission Tomography–Adaptive Radiotherapy in Stage III Non–Small Cell Lung Cancer: Another Attempt Toward Personalized Care

Erratum: Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor–Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic ...